+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Characterization of a lipopeptide-resistant strain of Candida albicans

Characterization of a lipopeptide-resistant strain of Candida albicans

Canadian Journal of Microbiology 43(2): 122-128

Lipopeptides are antifungal agents that inhibit cell wall beta-(1,3)-glucan biosynthesis in fungal organisms. A mutant resistant to lipopeptides was generated by UV mutagenesis and characterized. The Candida albicans mutant (LP3-1) was stable and showed resistance specificity to a broad range of lipopeptides and certain glycolipid inhibitors. Other antifungal agents with diverse modes of action had a normal minimum inhibitory concentration profile for LP3-1 compared with the wild-type strain (CCH 442). In the in vitro beta-(1,3)-glucan synthase assay, both the lipopeptides and papulacandin-related agents had considerably higher 50% inhibitory concentration values in the LP3-1 strain than in the wild-type strain. In reconstitution assays, the resistance factor was associated with the integral membrane pellet rather than the peripheral GTP-binding protein. The LP3-1 strain had a membrane lipid profile similar to that of the parent strain and was virulent in a murine model of systemic candidiasis. Taken together, these results indicate that the resistance factor is associated with the integral membrane component of beta-(1,3)-glucan synthase. Lipopeptides are common antifungal agents encountered during screening of natural products. The LP3-1 strain was resistant to natural product extracts known to contain various lipopeptides. Thus, LP3-1 can be used in a dereplication assay.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 002775354

Download citation: RISBibTeXText

PMID: 9090103

DOI: 10.1139/m97-016

Related references

Purification and characterization of fatty acid synthase from Candida albicans strain 4918 and two derived spontaneous cerulenin-resistant mutants. Journal of Medical and Veterinary Mycology 32(1): 13-20, 1994

Candida albicans (Monilia albicans) infection with blood stream invasion; report of a case with a strain clinically resistant to sulfonamide drugs and to penicillin in vitro. Ann. intern. Med, 22: 6, 886-889, 1945

The resistant strain of Candida albicans against trichomycin. Nippon Saikingaku Zasshi. 14: 29-31, 1959

Characterization of mannoproteins from a virulent Candida albicans strain and its derived, avirulent strain. Reviews of Infectious Diseases 10(Suppl. 2): S423-S427, 1988

Genetic characterization of a phospholipase C gene from Candida albicans: presence of homologous sequences in Candida species other than Candida albicans. Microbiology 144: 55-72, 1998

Characterisation of an induced fluconazole-resistant Candida albicans strain. Acta Microbiologica et Immunologica Hungarica 46(2-3): 337, 1999

Polymicrobial biofilm formation by Candida albicans, Actinomyces naeslundii, and Streptococcus mutans is Candida albicans strain and medium dependent. Medical Mycology 54(8): 856-864, 2016

Coaggregation of Candida albicans, Actinomyces naeslundii and Streptococcus mutans is Candida albicans strain dependent. Fems Yeast Research 15(5): Fov038, 2015

Immunomodulation by candida albicans crucial role of organ colonization and chronic infection with an attenuated agerminative strain of candida albicans for establishment of anti infectious protection. Journal of General Microbiology 134(9): 2583-2592, 1988

Identification of an amphotericin B resistant strain of Candida albicans using a rapid 3H-glucose incorporation microassay. Journal of Infection 33(3): 221-226, 1996

Impact of Farnesol as a Modulator of Efflux Pumps in a Fluconazole-Resistant Strain of Candida albicans. Microbial Drug Resistance 25(6): 805-812, 2019

Characterization of cerulenin-resistant mutants of Candida albicans. Infection and Immunity 51(1): 102-109, 1986

Characterization of a tunicamycin resistant mutant of candida albicans. Abstracts of the General Meeting of the American Society for Microbiology 91: 419, 1991

Matrine reduces yeast-to-hypha transition and resistance of a fluconazole-resistant strain of Candida albicans. Journal of Applied Microbiology 117(3): 618-626, 2014

Proteomic analysis reveals a metabolism shift in a laboratory fluconazole-resistant Candida albicans strain. Journal of Proteome Research 6(6): 2248-2256, 2007